Wells Fargo upgraded Johnson & Johnson to Overweight from Equal Weight with a price target of $212, up from $170.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Dentsply Sirona appoints Denti as Chief Commercial Officer
- Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
- Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
- Trump Trade: White House announces drug pricing deal with Pfizer
- Trump outlines plan for next round of Medicare drug price talks, Bloomberg says